Related Experiment Video
Updated: Feb 5, 2026
10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
14.0K
Loop diuretics in chronic heart failure: how to manage congestion?
Justas Simonavičius1,2,3, Christian Knackstedt4, Hans-Peter Brunner-La Rocca4
1Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. j.simonavicius@gmail.com.
Heart Failure Reviews
|September 9, 2018
Summary
Loop diuretics are key for managing chronic heart failure congestion, but evidence is limited. This review offers strategies for outpatient decongestion to improve patient outcomes.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Loop diuretics are essential for managing fluid overload in chronic heart failure (CHF).
- High-quality evidence supporting their outpatient use and safety is lacking.
- Congestion is linked to adverse outcomes in heart failure patients.
Purpose of the Study:
- To provide a comprehensive review of evidence regarding chronic loop diuretic use in heart failure.
- To offer clinical decision-making support for decongestion strategies in CHF.
- To present methods for assessing congestion and an algorithm for decongestion in outpatient settings.
Main Methods:
- Systematic literature review of studies on loop diuretics in chronic heart failure.
- Analysis of current guidelines and expert consensus on decongestion strategies.
- Development of practical tools for outpatient congestion assessment and management.
Main Results:
- Current evidence for loop diuretic efficacy and safety in outpatient CHF is limited.
- Expert consensus emphasizes avoiding congestion in heart failure management.
- There is a need for evidence-based strategies for outpatient decongestion.
Conclusions:
- Optimizing loop diuretic use and decongestion strategies is crucial for CHF care.
- Clinical decision support tools are needed for healthcare specialists.
- Further research is required to establish high-quality evidence for outpatient decongestion.
Keywords:
Chronic heart failureDecongestionDiuretic resistanceDiuretic therapyLoop diureticVolume overloadMore Related Videos
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
983
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
983
01:30Heart Failure V: Medical Management
330
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
330
01:29Heart Failure II: Pathophysiology
952
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
952
01:17Pathophysiology of Heart Failure
3.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
01:27Heart Failure I: Introduction
903
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
01:22Heart Failure VI: Adjunct Therapies
348
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348